grant

Functional Analysis of Novel Components of the Toxoplasma Inner Membrane Complex

Organization UNIVERSITY OF CALIFORNIA LOS ANGELESLocation LOS ANGELES, UNITED STATESPosted 1 Aug 2017Deadline 31 Dec 2026
NIHUS FederalResearch GrantFY20264-3 Hydrophobic RepeatAblationAcylationAffectAlveolarAlveolusAnimalsApicalApicomplexaArchitectureBindingBiotinylationBronchial AlveolusC-terminalCell BodyCell membraneCellsCellular MatrixCellular biologyCoccidiosisCoiled-Coil DomainCollaborationsComplementComplement ProteinsComplexConeCryo-electron tomographyCytoplasmic MembraneCytoskeletal FilamentsCytoskeletal ModelingCytoskeletal OrganizationCytoskeletal Organization ProcessCytoskeletal ReorganizationCytoskeletal SystemCytoskeletonDaughterDiseaseDisorderEimeria tenellaElementsEngineering / ArchitectureFundingGrantHumanInvadedLeft-Handed TwistLife StyleLifestyleMalariaMediatingMedicalMembraneMicro-tubuleMicrotubulesModern ManMolecularMolecular InteractionMotilityMotorNamesNeospora caninumOrganellesP falciparumP. falciparumP.falciparumPaludismParasitesPatternPeripheralPlasma MembranePlasmodium InfectionsPlasmodium falciparumPlayProcessProteinsProteomeReportingRoleSeriesShapesStructureSurgical suturesSuturesSystemT gondiiT gondii infectionT. gondiiT. gondii infectionToxoplasmaToxoplasma gondiiToxoplasma gondii InfectionToxoplasmosisVesicleWorkcell biologycomplementationcrosslinkcryo-EM tomographycryoEM tomographycryoelectron tomographydaughter celldesigndesigningelectron cryo-tomographyhuman pathogenin vivointracellular skeletonknock-downknockdownknockout genemembermembrane structurenamenamednamingnew drug targetnew drug treatmentsnew druggable targetnew drugsnew pharmacological therapeuticnew pharmacotherapy targetnew therapeutic targetnew therapeuticsnew therapynew therapy targetnext generation therapeuticsnon-natural amino acidsnon-proteinogenic amino acidsnonproteinogenic amino acidsnovelnovel drug targetnovel drug treatmentsnovel druggable targetnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel pharmacotherapy targetnovel therapeutic targetnovel therapeuticsnovel therapynovel therapy targetobligate intracellular parasitepathogenplasmalemmaprotein complexprotein functionscaffoldscaffoldingsegregationsocial roleunnatural amino acids
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Toxoplasma gondii and related apicomplexan parasites contain a specialized organelle called the inner

membrane complex (IMC) that plays essential roles in host cell invasion and daughter cell formation. The IMC

consists of flattened membrane vesicles and a supporting cytoskeletal meshwork that is flanked by the plasma

membrane and subpellicular microtubules at the periphery of the parasite. Recent in vivo biotinylation (BioID)

studies have revealed a surprising level of compartmentalization within the IMC organelle, with distinct groups

of proteins segregating to the cone-shaped apical cap, the body, or to the basal complex of both the cytoskeletal

and membrane subcompartments. Analyses from our group and others have exposed new essential functions

of the IMC including the role of the apical cap complex AC9/AC10/ERK7 in mounting the conoid which is essential

for organelle secretion and invasion as well as the conserved early daughter bud protein IMC32 that is essential

for replication. In this renewal, we will expand on these studies to determine precisely how these and other critical

IMC components are able to carry out their functions. First, we will determine the role of novel apical cap proteins

that are putative interactors of the AC9/AC10/ERK7 complex and assess their role in apical cap function and

conoid assembly. We will then explore how IMC32 collaborates with the newly discovered partner IMC48 to

function at the earliest stages of parasite division and use these proteins to further explore the early daughter

bud proteome. Finally, we will exploit our recently developed photoreactive unnatural amino acid system as well

as cryo-electron tomography to determine how critical alveolins of the parasite cytoskeleton are organized to

serve as scaffolds for the organelle. Together, this project will promote a much deeper understanding of the

architecture and function of the Toxoplasma IMC. As this organelle is parasite-specific and not present in its

human host, determining precisely how these essential IMC components function promises to enable the design

of novel therapies against T. gondii and other apicomplexan parasites.

Grant Number: 5R01AI123360-09
NIH Institute/Center: NIH

Principal Investigator: Peter Bradley

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →